An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

The vast majority of women infected with human immunodeficiency virus (HIV) will be co-
infected with human papillomavirus (HPV). The interaction between the two sexually …

Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …

Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-
adjuvanted vaccine against non-vaccine oncogenic HPV types in the end-of-study analysis …

The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)‐
related morbidity, as well as the evidence and potential practice recommendations …

Purpose: Cytology-based screening has limited sensitivity to detect prevalent cervical
precancers. Human papilloma virus (HPV) DNA testing is highly sensitive and provides a …

Background Information on human papillomavirus (HPV) type distribution is necessary to
evaluate the potential impact of current and future HPV vaccines. We estimated the relative …

Clinical microbiology laboratories worldwide have historically relied on phenotypic methods
(ie, culture and biochemical tests) for detection, identification and characterization of …

Cervical cancer is the second most common cancer in females worldwide. It is well-
established that Human Papillomavirus (HPV) infections play a critical role in the …

Background Persistent infections with carcinogenic human papillomavirus (HPV) types are
the necessary cause of cervical cancer. We recently demonstrated that the HPV16 genome …